Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

ClinicalTrials.gov ID: NCT06217302

Public ClinicalTrials.gov record NCT06217302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 7:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effectiveness and Safety of Sotagliflozin in Slowing Kidney Function Decline in Persons With Type 1 Diabetes and Moderate to Severe Diabetic Kidney Disease

Study identification

NCT ID: NCT06217302
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Alessandro Doria; Other
Enrollment: 150 participants

Conditions and interventions

Conditions

Interventions

Placebo Drug
Sotagliflozin Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 30, 2024
Primary completion: Nov 30, 2028
Completion: Apr 30, 2029
Last update posted: Mar 23, 2026

2024 – 2029

United States locations

U.S. sites: 13
U.S. states: 11
U.S. cities: 13

Facility	City	State	ZIP	Site status
Stanford University Medical Center	Stanford	California	94305	Recruiting
Barbara Davis Center / University of Colorado Denver	Aurora	Colorado	80045	Recruiting
AdventHealth	Orlando	Florida	32803	Recruiting
Northwestern University Feinberg School of Medicine	Chicago	Illinois	60611	Recruiting
Joslin Diabetes Center	Boston	Massachusetts	02215	Recruiting
Washington University	St Louis	Missouri	63110	Recruiting
SUNY Upstate Medical University	Syracuse	New York	13210	Recruiting
Albert Einstein College of Medicine / Montefiore Medical Center	The Bronx	New York	10461	Recruiting
Cleveland Clinic Foundation	Cleveland	Ohio	44195	Recruiting
Oregon Health and Science University	Portland	Oregon	97239	Recruiting
University of Texas Southwestern	Dallas	Texas	75390	Recruiting
University of Washington	Seattle	Washington	98105	Recruiting
Providence Sacred Heart Medical Center	Spokane	Washington	99204	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06217302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 23, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06217302 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →